News

460 women from Denmark, Sweden and Spain participated in the study, which shows similar ongoing pregnancy rates after frozen compared to fresh embryo transfer.

On the 5th of July, the European Society of Human Reproduction and Embryology (ESHRE) kicked off its 36th Annual Meeting as a virtual conference with 12,191 participants from all over the world.

Eva Hoffmann is one of the 63 leading scientists from 25 countries, who have been bestowed the lifetime honour of EMBO Membership in recognition of their remarkable research achievements.

On the 6th of May, Fertility & Sterility under the American Society of Reproductive Medicine published the study, which used data from the Fetal Programming of Semen Quality (FEPOS) cohort, co-funded by ReproUnion.

Fostering the next generation of researchers is vital to meet the future demands of managing and preventing infertility problems. In 2015-18 ReproUnion supported 24 research projects.

On the 10th of March, ReproUnion researchers, Nina Mørup and Kristian Almstrup published a review article in the prominent journal Nature Reviews Urology. The authors summarise how microRNAs can be potential new markers of testicular cancer.

One of the highlights for ReproUnion in 2019 was the renewal of the patient mobility agreement between the Capital Region of Denmark and Region Skåne. This will enable more patients to receive specialized reproductive treatment across the Danish/Swedish border.

Regional Chairmen and Deans in Lund, Malmö and Copenhagen stand behind ReproUnion in this opinion article, which Dagens Medicin in Sweden published in December 2019. It,highlights the concerning infertility statistics, as well as the need to continue involving new collaboration partners to address prevention and develop new reproductive treatments. Click on to read the full article (in Swedish).

FEPOS investigates the possible causes between male infertility and what was passed on at the fetal stage, by paring samples from mothers and their sons. Data from 100.000 mothers originates from the Danish National Birth Cohort and since 2017 FEPOS has collected biological samples and data from 1000 sons.

ReproUnion 2.0 marks the beginning of a new research and innovation paradigm within reproductive medicine in Greater Copenhagen. With seven signatures on the formal agreement, the partnership stands ready to continuously use the regional innovation force, international collaboration partners, and the triple-helix structure as leverage in its effort to solve five major global reproductive challenges, which are of great individual and social concern.